More recently, neutrophil to lymphocyte ratios, serum inflammatory markers, as well as serum, tissue and pleural effusion Vascular endothelial growth factor (VEGF) levels and and BRCA1-Associated Protein 1 (BAP1) mutation BAP1 status have been related to outcomes among MM patients [2,3,4,5,6]. Here, VEGFA is linked to Miyoshi myopathy.